Abstract
Artificial intelligence (AI) is defined as a computer science involving program development aiming to reproduce human cognition to analyze complex data. Artificial intelligence has rapidly developed in the medical field. In dermatology, its development is relatively new and is generally used in the diagnostic, especially for skin imaging analysis and classification, and also for risk assessment. The greatest advances have been primarily in the diagnosis of melanoma, followed by the assessment of psoriasis, ulcers, and various other skin diseases. The use of AI has shown good accuracy and is comparable to dermatologists in various studies, especially related to melanoma and skin tumors. However, several obstacles exist in the application of AI to daily clinical practice, including generalizability, image standardization, the need for large data quantities, and legal and privacy aspects. In current developments, AI should be aimed at helping enhance the decision-making of clinicians.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Indonesian Journal of Biomedicine and Clinical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.